The results demonstrated that RBPP-P treatment significantly improved insulin sensitivity to increase glucose uptake, but not RBPP-N, indicating that pectic polysaccharide could benefit to patients with obesity-associated diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.